Compounds > desloratadine
Page last updated: 2024-09-03

desloratadine and Breast Neoplasms

desloratadine has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gust, R; Huang, W; Liu, W; Qian, H; Zhang, H; Zhang, T; Zhou, J; Zhu, H1
Broberg, P; Einefors, R; Fritz, I; Olsson, H; Wagner, P1

Other Studies

2 other study(ies) available for desloratadine and Breast Neoplasms

ArticleYear
Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Assay; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclization; Disease Models, Animal; Drug Design; Female; Humans; Inhibitory Concentration 50; Mice; Pyrimidines; Thiourea

2012
Desloratadine and loratadine stand out among common H
    Acta oncologica (Stockholm, Sweden), 2020, Volume: 59, Issue:9

    Topics: Breast; Breast Neoplasms; Drug Prescriptions; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Receptors, Estrogen; Registries; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Sweden; Tumor Microenvironment

2020